QuidelOrtho names Sanjeev Sharma as VP of investor relations

QuidelOrtho Corporation (NASDAQ: QDEL) has appointed Sanjeev Sharma, CFA, as Vice President of Investor Relations, effective September 28, 2026, according to a company statement.

Sharma brings more than 20 years of experience in investor relations, corporate strategy, and equity research. He most recently served as Senior Director of Investor Relations at Teva Pharmaceuticals, where he worked with senior leadership on investor communications. Before that, he spent more than a decade at Genpact in investor relations and business strategy roles, and nearly six years earlier in sell-side equity research. He holds a master's degree in finance and the CFA designation.

Micah Young, Chief Financial Officer of QuidelOrtho, said Sharma's "experience partnering with executive teams and translating strategy and performance into a clear investor narrative will be especially valuable as we sharpen our communications and deepen our engagement with shareholders and analysts."

You May Also Be Interested In

• Pliant Therapeutics names siRNA research veteran as SVP
• QuidelOrtho to Report Third Quarter 2026 Financial Results on November 3, 2026
• XCF Global names new president and CFO amid leadership changes